Estrogen receptor-α signaling maintains immunometabolic function in males and is obligatory for exercise-induced amelioration of nonalcoholic fatty liver.
Adipose Tissue, White
/ metabolism
Adiposity
/ genetics
Animals
Estrogen Receptor alpha
/ genetics
Female
Glucose Intolerance
/ genetics
Inflammation
/ genetics
Insulin Resistance
/ genetics
Liver
/ metabolism
Male
Mice
Mice, Knockout
Muscle, Skeletal
/ metabolism
Non-alcoholic Fatty Liver Disease
/ metabolism
Physical Conditioning, Animal
/ physiology
estrogen receptor-α
exercise
fatty liver
insulin resistance
metaflammation
obesity
Journal
American journal of physiology. Endocrinology and metabolism
ISSN: 1522-1555
Titre abrégé: Am J Physiol Endocrinol Metab
Pays: United States
ID NLM: 100901226
Informations de publication
Date de publication:
01 02 2019
01 02 2019
Historique:
pubmed:
5
12
2018
medline:
22
11
2019
entrez:
5
12
2018
Statut:
ppublish
Résumé
The role of estrogen receptor-α (ERα) signaling in immunometabolic function is established in females. However, its necessity in males, while appreciated, requires further study. Accordingly, we first determined whether lower metabolic function in male mice compared with females is related to reduced ERα expression. ERα protein expression in metabolically active tissues was lower in males than in females, and this lower expression was associated with worse glucose tolerance. Second, we determined whether ERα is required for optimal immunometabolic function in male mice consuming a chow diet. Despite lower expression of ERα in males, its genetic ablation (KO) caused an insulin-resistant phenotype characterized by enhanced adiposity, glucose intolerance, hepatic steatosis, and metaflammation in adipose tissue and liver. Last, we determined whether ERα is essential for exercise-induced metabolic adaptations. Twelve-week-old wild-type (WT) and ERα KO mice either remained sedentary (SED) or were given access to running wheels (WR) for 10 wk while fed an obesogenic diet. Body weight and fat mass were lower in WR mice regardless of genotype. Daily exercise obliterated immune cell infiltration and inflammatory gene transcripts in adipose tissue in both genotypes. In the liver, however, wheel running suppressed hepatic steatosis and inflammatory gene transcripts in WT but not in KO mice. In conclusion, the present findings indicate that ERα is required for optimal immunometabolic function in male mice despite their reduced ERα protein expression in metabolically active tissues. Furthermore, for the first time, we show that ERα signaling appears to be obligatory for exercise-induced prevention of hepatic steatosis.
Identifiants
pubmed: 30512987
doi: 10.1152/ajpendo.00259.2018
pmc: PMC6397364
doi:
Substances chimiques
Esr1 protein, mouse
0
Estrogen Receptor alpha
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
E156-E167Subventions
Organisme : BLRD VA
ID : I01 BX003271
Pays : United States
Organisme : NHLBI NIH HHS
ID : K01 HL125503
Pays : United States
Organisme : NHLBI NIH HHS
ID : K08 HL129074
Pays : United States
Références
Am J Physiol Regul Integr Comp Physiol. 2015 Sep;309(5):R594-602
pubmed: 26180183
Mol Metab. 2014 Jan 09;3(2):177-90
pubmed: 24634829
Dis Model Mech. 2010 Sep-Oct;3(9-10):525-34
pubmed: 20713647
Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3:306-21
pubmed: 26033249
Diabetes. 2013 Feb;62(2):424-34
pubmed: 22966069
Diabetologia. 2016 Oct;59(10):2068-79
pubmed: 27393135
J Biol Chem. 2005 Oct 28;280(43):35983-91
pubmed: 16109719
ScientificWorldJournal. 2014;2014:593927
pubmed: 25152917
Nature. 2006 Dec 14;444(7121):860-7
pubmed: 17167474
Am J Physiol Gastrointest Liver Physiol. 2008 Mar;294(3):G619-26
pubmed: 18174272
PLoS Genet. 2008 Jun 27;4(6):e1000108
pubmed: 18584035
Mol Metab. 2013 Jun 04;2(3):227-42
pubmed: 24049737
Clin Chem. 2009 Mar;55(3):425-38
pubmed: 19181734
Am J Physiol Endocrinol Metab. 2009 May;296(5):E1164-71
pubmed: 19276393
Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12729-34
pubmed: 11070086
Med Sci Sports Exerc. 2008 Feb;40(2):252-7
pubmed: 18202578
Adipocyte. 2018 Jan 2;7(1):20-34
pubmed: 29226756
Am J Physiol Regul Integr Comp Physiol. 2018 Apr 1;314(4):R584-R597
pubmed: 29351429
J Intern Med. 1999 Aug;246(2):133-8
pubmed: 10447781
ILAR J. 2004;45(4):455-61
pubmed: 15454684
Hepatology. 2012 Jun;55(6):1738-45
pubmed: 22213436
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11162-6
pubmed: 8248223
J Physiol. 2016 Sep 15;594(18):5271-84
pubmed: 27104887
Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1476-81
pubmed: 9037078
Acta Physiol (Oxf). 2010 Dec;200(4):325-38
pubmed: 20590530
Reprod Fertil Dev. 2001;13(4):211-9
pubmed: 11800160
Hepatology. 2010 Aug;52(2):774-88
pubmed: 20683968
Am J Physiol Endocrinol Metab. 2006 May;290(5):E961-7
pubmed: 16352667
Physiol Rev. 2017 Jul 1;97(3):995-1043
pubmed: 28539434
Histochem Cell Biol. 2007 Jan;127(1):95-107
pubmed: 16897031
Am J Physiol Regul Integr Comp Physiol. 2017 Jan 1;312(1):R74-R84
pubmed: 27881400
Cell Microbiol. 2014 Oct;16(10):1484-92
pubmed: 25073615
J Clin Invest. 2003 Dec;112(12):1821-30
pubmed: 14679177
J Steroid Biochem Mol Biol. 2018 Feb;176:31-37
pubmed: 28223150
Biol Sport. 2016 Dec;33(4):381-391
pubmed: 28090143
FEBS Lett. 2017 Oct;591(19):3061-3088
pubmed: 28677122
J Bone Miner Res. 2004 Nov;19(11):1758-65
pubmed: 15476574
Endocrinology. 2001 Nov;142(11):4751-7
pubmed: 11606440
Am J Physiol Endocrinol Metab. 2014 May 15;306(10):E1188-97
pubmed: 24691030
Am J Physiol Endocrinol Metab. 2014 Feb;306(3):E300-10
pubmed: 24326426
J Cardiometab Syndr. 2009 Spring;4(2):113-9
pubmed: 19614799
Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E304-19
pubmed: 19920214
Physiol Behav. 2006 Jan 30;87(1):39-44
pubmed: 16181647
Hepatology. 2009 Oct;50(4):1105-12
pubmed: 19637289
Med Sci Sports Exerc. 2015 Mar;47(3):556-67
pubmed: 24983336
Nature. 2017 Feb 8;542(7640):177-185
pubmed: 28179656
Endocrinology. 1996 Nov;137(11):4796-805
pubmed: 8895349
Int J Obes Relat Metab Disord. 2002 Aug;26(8):1103-9
pubmed: 12119576
Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G874-83
pubmed: 21350190
J Clin Invest. 2006 Jun;116(6):1494-505
pubmed: 16691291
J Endocrinol. 2017 Nov;235(2):97-109
pubmed: 28765264
Heliyon. 2018 Sep 11;4(9):e00772
pubmed: 30211334
Biochem Biophys Res Commun. 2000 Nov 30;278(3):640-5
pubmed: 11095962
Reprod Domest Anim. 2011 Feb;46(1):1-7
pubmed: 19645857
Am J Physiol Endocrinol Metab. 2017 Oct 1;313(4):E402-E412
pubmed: 28655717
Diabetes. 2013 Dec;62(12):4098-108
pubmed: 23903353
Nutr Res. 2016 Mar;36(3):280-9
pubmed: 26923515
Mediators Inflamm. 2010;2010:
pubmed: 20936118
J Hepatol. 2006 Oct;45(4):592-9
pubmed: 16837098
Med Clin North Am. 2011 Sep;95(5):875-92
pubmed: 21855697
J Gastroenterol Hepatol. 2018 Mar;33(3):747-755
pubmed: 28884481
J Clin Invest. 1997 May 15;99(10):2429-37
pubmed: 9153286
Can J Physiol Pharmacol. 1984 Jun;62(6):695-9
pubmed: 6744113
Endocrinology. 1998 Dec;139(12):5070-81
pubmed: 9832446
Gend Med. 2009;6 Suppl 1:60-75
pubmed: 19318219
J Clin Endocrinol Metab. 2013 Jan;98(1):E17-24
pubmed: 23118428
J Clin Invest. 2003 Dec;112(12):1796-808
pubmed: 14679176
Am J Physiol Regul Integr Comp Physiol. 2018 Feb 1;314(2):R252-R264
pubmed: 29141949
Breast Cancer Res. 2000;2(5):345-52
pubmed: 11250727
Sci Signal. 2013 May 21;6(276):ra36
pubmed: 23695162